drugset / Trial / NCT01455844
TRIal For Efficacy of Capre on hyperTriglyceridemiA
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether CaPre(TM), given at doses 1.0g or 2.0g for 12 weeks, has an effect on fasting plasma triglycerides in patients with mild to high hypertriglyceridemia as compared to a placebo.
Timeline
- Start
- 2011-09
- Primary completion
- 2014-06
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CaPre | Other / unclassified | 1 g | — |
| Subject | CaPre | Other / unclassified | 2 g | — |